Investigational Medical Therapies for Endometriosis: Current Data and Future Trends

No abstract is available for this paper.

• Publication year

  2017

• Venue

  Seminars in Reproductive Medicine

• Publication date

  2017-07-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1055/s-0037-1604095PMID 29036739
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Treatment of Endometriosis‐Associated Pain with Elagolix, an Oral GnRH Antagonist

  2017cited by this paper
• Efficacy of Anti-VEGF/VEGFR Agents on Animal Models of Endometriosis: A Systematic Review and Meta-Analysis

  2016cited by this paper
• Effect of rapamycin on endometriosis in mice

  2016cited by this paper
• Vascular endothelial growth factor receptor-2 inhibitor cediranib causes regression of endometriotic lesions in a rat model.

  2015cited by this paper
• Vaginally Administered Danazol: An Overlooked Option in the Treatment of Rectovaginal Endometriosis?

  2015cited by this paper
• Characterization of anastrozole effects, delivered by an intravaginal ring in cynomolgus monkeys.

  2015cited by this paper
• Effects of Pazopanib, Sunitinib, and Sorafenib, Anti-VEGF Agents, on the Growth of Experimental Endometriosis in Rats

  2015cited by this paper
• Protective Effects of Colchicine in an Experimental Rat Endometriosis Model

  2015cited by this paper
• Emerging therapy for endometriosis

  2015cited by this paper
• Does dienogest influence the inflammatory response of endometriotic cells? A systematic review

  2015cited by this paper
• Is montelukast effective in regression of endometrial implants in an experimentally induced endometriosis model in rats?

  2015cited by this paper
• Dienogest in the treatment of endometriosis: systematic review

  2015cited by this paper
• Effect of SKI2670, a novel, orally active, non-peptide GnRH antagonist, on hypothalamic-pituitary-gonadal axis.

  2015cited by this paper
• Aromatase inhibitor (anastrozole) affects growth of endometrioma cells in culture.

  2015cited by this paper
• Elagolix, a Novel, Orally Bioavailable GnRH Antagonist under Investigation for the Treatment of Endometriosis-Related Pain

  2015cited by this paper
• Selective progesterone receptor modulators: a class with multiple actions and applications in reproductive endocrinology, and gynecology

  2014cited by this paper
• Expression of vascular endothelial growth factor C and anti-angiogenesis therapy in endometriosis.

  2014cited by this paper
• Treatment with Bazedoxifene and Conjugated Estrogens Results in Regression of Endometriosis in a Murine Model1

  2014cited by this paper
• The Effects of Ranibizumab on Surgically Induced Endometriosis in a Rat Model

  2013cited by this paper
• Aromatase inhibitor treatment limits progression of peritoneal endometriosis in baboons.

  2013cited by this paper
• PPARγ activation inhibits growth and survival of human endometriotic cells by suppressing estrogen biosynthesis and PGE2 signaling.

  2013cited by this paper
• Anastrozole and celecoxib for endometriosis treatment, good to keep them apart?

  2013cited by this paper
• The Efficacy of Bevacizumab, Sorafenib, and Retinoic Acid on Rat Endometriosis Model

  2013cited by this paper
• A tumor necrosis factor-α inhibitor reduces the embryotoxic effects of endometriotic peritoneal fluid.

  2013cited by this paper
• Postoperative Levonorgestrel-Releasing Intrauterine System for Pelvic Endometriosis-Related Pain: A Randomized Controlled Trial

  2012cited by this paper
• Anti-angiogenic treatment strategies for the therapy of endometriosis.

  2012cited by this paper
• Dienogest inhibits aromatase and cyclooxygenase-2 expression and prostaglandin E₂ production in human endometriotic stromal cells in spheroid culture.

  2012cited by this paper
• Effect of letrozole on estradiol production and P450 aromatase messenger RNA expression of cultured luteinized granulosa cells from women with and without endometriosis.

  2012cited by this paper
• Dienogest inhibits Toll-like receptor 4 expression induced by costimulation of lipopolysaccharide and high-mobility group box 1 in endometrial epithelial cells.

  2011cited by this paper
• Treatment with bazedoxifene, a selective estrogen receptor modulator, causes regression of endometriosis in a mouse model.

  2011cited by this paper
• Comparison of aromatase inhibitor (letrozole) and immunomodulators (infliximab and etanercept) on the regression of endometriotic implants in a rat model.

  2011cited by this paper
• Postoperative medical treatment of chronic pelvic pain related to severe endometriosis: levonorgestrel-releasing intrauterine system versus gonadotropin-releasing hormone analogue.

  2011cited by this paper
• Effect of Vascular Endothelial Growth Factor Inhibition on Endometrial Implant Development in a Murine Model of Endometriosis

  2011cited by this paper
• Etanercept causes regression of endometriotic implants in a rat model

  2011cited by this paper
• Tumor necrosis factor-α activates estrogen signaling pathways in endometrial epithelial cells via estrogen receptor α.

  2011cited by this paper
• Use of aromatase inhibitors to treat endometriosis-related pain symptoms: a systematic review

  2011cited by this paper
• Dienogest, a synthetic progestin, inhibits prostaglandin E2 production and aromatase expression by human endometrial epithelial cells in a spheroid culture system.

  2011cited by this paper
• A Long-Acting Tumor Necrosis Factor α-Binding Protein Demonstrates Activity in Both In Vitro and In Vivo Models of Endometriosis

  2010cited by this paper
• Intrauterine administration of CDB-2914 (Ulipristal) suppresses the endometrium of rhesus macaques.

  2010cited by this paper
• Comparison of the effects of raloxifene and anastrozole on experimental endometriosis.

  2010cited by this paper
• Effect of aromatase inhibitors on ectopic endometrial growth and peritoneal environment in a mouse model of endometriosis.

  2010cited by this paper
• The effects of metformin and letrozole on endometriosis and comparison of the two treatment agents in a rat model.

  2010cited by this paper
• Peroxisome-proliferator activator receptor-gamma activation decreases attachment of endometrial cells to peritoneal mesothelial cells in an in vitro model of the early endometriotic lesion.

  2009cited by this paper
• Dopamine agonist administration causes a reduction in endometrial implants through modulation of angiogenesis in experimentally induced endometriosis.

  2009cited by this paper
• Danazol enhances Fas-mediated apoptosis in human endometrial epithelial cells within normal physiology.

  2009cited by this paper
• Effects of the levonorgestrel-releasing intrauterine system on cell proliferation, Fas expression and steroid receptors in endometriosis lesions and normal endometrium.

  2009cited by this paper
• Is aromatase expression in the endometrium the cause of endometriosis and related infertility?

  2009cited by this paper
• High concentrations of progesterone and mifepristone mutually reinforce cell cycle retardation and induction of apoptosis.

  2009cited by this paper
• Non-steroidal targets in the diagnosis and treatment of endometriosis.

  2008cited by this paper
• Emerging drugs for endometriosis

  2008cited by this paper
• Comparison of the effects of cetrorelix, a GnRH antagonist, and leuprolide, a GnRH agonist, on experimental endometriosis

  2008cited by this paper
• TLR3 and TLR4 expression in healthy and diseased human endometrium

  2008cited by this paper
• Systematic review of the effects of aromatase inhibitors on pain associated with endometriosis

  2008cited by this paper
• Systematic review of the effects of aromatase inhibitors on pain associated with endometriosis

  2008cited by this paper
• In vitro and in vivo characterization of a novel nonsteroidal, species-specific progesterone receptor modulator, PRA-910.

  2007cited by this paper
• Effect of recombinant human endostatin on endometriosis in mice

  2007cited by this paper
• PPAR-gamma receptor ligand induces regression of endometrial explants in baboons: a prospective, randomized, placebo- and drug-controlled study.

  2007cited by this paper
• Two Unsuccessful Clinical Trials on Endometriosis and a Few Lessons Learned

  2007cited by this paper
• An in vivo murine model of rosiglitazone use in pregnancy.

  2006cited by this paper
• Rapamycin induces regression of endometriotic lesions by inhibiting neovascularization and cell proliferation

  2006cited by this paper
• Expression of aromatase (P450 aromatase/CYP19) in peritoneal and ovarian endometriotic tissues and deep endometriotic (adenomyotic) nodules of the rectovaginal septum.

  2006cited by this paper
• Effect of Peroxisome Proliferator—Activated Receptor-γ Agonist Rosiglitazone on the Induction of Endometriosis in an Experimental Rat Model

  2006cited by this paper
• Recombinant Human TNFRSF1A (r-hTBP1) Inhibits the Development of Endometriosis in Baboons: A Prospective, Randomized, Placebo- and Drug-Controlled Study1

  2006cited by this paper
• Inhibition of Proliferation of Endometrial Stromal Cells by Trichostatin A, RU486, CDB-2914, N-Acetylcysteine, and ICI 182780

  2006cited by this paper
• Levonorgestrel-releasing intrauterine device (LNG-IUD) for symptomatic endometriosis following surgery.

  2006cited by this paper
• Treatment with anti-TNF monoclonal antibody (c5N) reduces the extent of induced endometriosis in the baboon.

  2006cited by this paper
• Effect of peroxisome proliferator-activated receptor-gamma agonist rosiglitazone on the induction of endometriosis in an experimental rat model.

  2006cited by this paper
• Endostatin inhibits the growth of endometriotic lesions but does not affect fertility.

  2005cited by this paper
• The efficacy, side-effects and continuation rates in women with symptomatic endometriosis undergoing treatment with an intra-uterine administered progestogen (levonorgestrel): a 3 year follow-up.

  2005cited by this paper
• Efficacy of anti-tumor necrosis factor therapy in the treatment of spontaneous endometriosis in baboons.

  2004cited by this paper
• Antiangiogenesis therapy for endometriosis.

  2004cited by this paper
• Comparison of a levonorgestrel-releasing intrauterine device versus expectant management after conservative surgery for symptomatic endometriosis: a pilot study.

  2004cited by this paper
• Peroxisome proliferator-activated receptor-gamma induces regression of endometrial explants in a rat model of endometriosis.

  2004cited by this paper
• Effect of long-term treatment with low doses of the LHRH antagonist Cetrorelix on pituitary receptors for LHRH and gonadal axis in male and female rats.

  2004cited by this paper
• Case Reports of Heart Failure after Therapy with a Tumor Necrosis Factor Antagonist

  2003cited by this paper
• Effects of an Antiprogestin Onapristone on the Endometrium of Bonnet Monkeys: Morphometric and Ultrastructural Studies

  2003cited by this paper
• Treatment of rheumatoid arthritis with tumor necrosis factor inhibitors may predispose to significant increase in tuberculosis risk: a multicenter active-surveillance report.

  2003cited by this paper
• Comparison of a levonorgestrel-releasing intrauterine device versus expectant management after conservative surgery for symptomatic endometriosis: a pilot study

  2003cited by this paper
• Cytokine regulation by peroxisome proliferator-activated receptor gamma in human endometrial cells.

  2003cited by this paper
• Gonadotropin-releasing hormone agonist and danazol normalize aromatase cytochrome P450 expression in eutopic endometrium from women with endometriosis, adenomyosis, or leiomyomas.

  2003cited by this paper
• PPAR-γ Decreases Endometrial Stromal Cell Transcription and Translation of RANTES in Vitro

  2002cited by this paper
• Tumor necrosis factor antagonist therapy and lymphoma development: twenty-six cases reported to the Food and Drug Administration.

  2002cited by this paper
• PPAR-gamma decreases endometrial stromal cell transcription and translation of RANTES in vitro.

  2002cited by this paper
• Human endometrial angiogenesis.

  2001cited by this paper
• Effects of the levonorgestrel-releasing intrauterine system on proliferation and apoptosis in the endometrium.

  2001cited by this paper
• Ability of recombinant human TNF binding protein-1 (r-hTBP-1) to inhibit the development of experimentally-induced endometriosis in rats.

  2000cited by this paper
• The selective estrogen receptor modulator, raloxifene: an overview of nonclinical pharmacology and reproductive and developmental testing.

  1998cited by this paper
• Novel vaginal danazol ring therapy for pelvic endometriosis, in particular deeply infiltrating endometriosis.

  1998cited by this paper
• Aromatase expression in endometriosis.

  1996cited by this paper
• Ovarian steroid regulation of vascular endothelial growth factor in the human endometrium: implications for angiogenesis during the menstrual cycle and in the pathogenesis of endometriosis.

  1996cited by this paper
• Time-related effects of RU486 treatment in experimentally induced endometriosis in the rat.

  1993cited by this paper
• Direct effects of medroxyprogesterone acetate, danazol, and leuprolide acetate on endometrial stromal cell proliferation in vitro.

  1992cited by this paper
• Reproductive Biology and Endocrinology Role of Nonhuman Primate Models in the Discovery and Clinical Development of Selective Progesterone Receptor Modulators (sprms)

  year unknowncited by this paper

• Sunitinib induces primary ectopic endometrial cell apoptosis through up‐regulation of STAT1 in vitro

  2020cites this paper